Supreme Court grants Novartis request to halt Gilenya patent cancellation
The Swiss company said it would suffer irreparable harm if generics for the multiple sclerosis drug were allowed to enter the market before the higher court reviews the merits of its case.
Supreme Court grants Novartis request to halt Gilenya patent cancellation
The Swiss company said it would suffer irreparable harm if generics for the multiple sclerosis drug were allowed to enter the market before the higher court reviews the merits of its case.